Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study

A multicentre phase 2 trial (single-stage design) was undertaken to test the efficacy and toxicity of carboplatin (AUC 6 according to Calvert) plus paclitaxel (175 mg/m(2)3-h infusion) every 4 weeks in the first line treatment of patients affected by extensive small cell lung cancer. The primary end...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gridelli, C, Manzione, L, Perrone, F, Veltri, E, Cioffi, R, Caprio, M Grazia, Frontini, L, Rossi, A, Barletta, E, Barzelloni, M L, Bilancia, D, Gallo, C
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2001
Assuntos:
Regular Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363602/
https://ncbi.nlm.nih.gov/pubmed/11139310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1541
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados